Risk factors for cataract subtypes waterclefts and retrodots: Two case-control studies

Eye

Volumn 20, Issue 11, 2006, Pages 1254-1267

  Durant, J S ^a   Frost, N A ^b,d   Trivella, M ^c,d   Sparrow, J M ^a  

^a BRISTOL EYE HOSPITAL   (United Kingdom)

^b TORBAY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANALGESIC AGENT; ASCORBIC ACID; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IBUPROFEN; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; RETINOL; UREA; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CATARACT; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUTRITION; PREVALENCE; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; SUN EXPOSURE; UNITED KINGDOM; UNIVARIATE ANALYSIS; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 33750727990     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702087     Document Type: Article

References (70)

1. WHO. Magnitude and causes of visual impairment, World Health Organisation Fact Sheet No. 282 2004. http://www.who.int/mediacentre/ factsheets/fs282/en/.
2. Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya'ale D, Negrel AD et al. 2002 global update of available data on visual impairment: A compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004; 11: 67-115.
3. Brian G, Taylor H. Cataract blindness - challenges for the 21st century. Bull World Health Organ 2001; 79: 249-256.
4. Sparrow JM, Frost NA. How should cataracts be measured? Eye 2004; 18: 763-764.
5. Thylefors B. The World Health Organization's programme for the prevention of blindness. Int Ophthalmol 1990; 14: 211-219.
6. Deane JS, Hall AB, Thompson JR, Rosenthal AR. Prevalence of lenticular abnormalities in a population-based study: Oxford Clinical Cataract Grading in the Melton Eye Study. Ophthalmic Epidemiol 1997; 4: 195-206.
7. Brown NA. The morphology of cataract and visual performance. Eye 1993; 7(Part 1): 63-67.
8. Bron AJ, Brown NA. Perinuclear lens retrodots: A role for ascorbate in cataractogenesis. Br J Ophthalmol 1987; 71: 86-95.
9. Hemenger RP. Light scatter in cataractous lenses. Ophthalmic Physiol Opt 1990; 10: 394-396.
10. Brown N, Shun-Shin G. Morphological correlations of clinical lens changes: Non-opaque lens defects. Prog Retin Eye Res 1995; 14: 453-472.
11. Frost NA, Sparrow JM, Moore L. Associations of human crystalline lens retrodots and waterclefts with visual impairment: An observational study. Invest Ophthalmol Vis Sci 2002; 43: 2105-2109.
12. Shun-Shin G, Vrensen G, Brown N, Willekens B, Bron A, McDonald B. Does the pathogenesis of waterclefts reside in the lens membrane. Eurage Top Ageing Res Europe 1991; 15: 261-271.
13. Brown NP, Harris ML, Shun-Shin GA, Vrensen GF, Willekens B, Bron AJ. Is cortical spoke cataract due to lens fibre breaks? The relationship between fibre folds, fibre breaks, waterclefts and spoke cataract. Eye 1993; 7(Part 5): 672-679.
14. Thompson JR, Deane JS, Hall AB, Rosenthal AR. Associations between lens features assessed in the Oxford Clinical Cataract Classification and Grading System. Ophthalmic Epidemiol 1997; 4: 207-212.
15. Shun-Shin GA, Bron AJ, Brown NP, Sparrow JM. The relationship between central nuclear scatter and perinuclear retrodots in the human crystalline lens. Eye 1992; 6(Part 4): 407-410.
16. West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 1995; 39: 323-334.
17. Frost A, Hopper C, Frankel S, Peters TJ, Durant J, Sparrow J. The population requirement for cataract extraction: A cross-sectional study. Eye 2001; 15: 745-752.
18. Frost A, Eachus J, Sparrow J, Peters TJ, Hopper C, Davey-Smith G et al. Vision-related quality of life impairment in an elderly UK population: associations with age, sex, social class and material deprivation. Eye 2001; 15: 739-744.
19. Eachus J, Williams M, Chan P, Davey-Smith G, Grainge M, Donovan J et al. Deprivation and cause specific morbidity: Evidence from the Somerset and Avon survey of health. BMJ 1996; 312: 287-292.
20. Sparrow JM, Bron AJ, Brown NA, Ayliffe W, Hill AR. The Oxford Clinical Cataract Classification and Grading System. Int Ophthalmol 1986; 9: 207-225.
21. Sparrow NA, Frost NA, Pantelides EP, Laidlaw DA. Decimalization of The Oxford Clinical Cataract Classification and Grading System. Ophthalmic Epidemiol 2000; 7: 49-60.
22. Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. HMSO: London, 1991.
23. Younan C, Mitchell P, Cumming R, Rochtchina E, Panchapakesan J, Tumuluri K. Cardiovascular disease, vascular risk factors and the incidence of cataract and cataract surgery: The Blue Mountains Eye Study. Ophthalmic Epidemiol 2003; 10: 227-240.
24. Jacques PF, Moeller SM, Hankinson SE, Chylack Jr LT, Rogers G, Tung W et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr 2003; 78: 400-405.
25. Caulfield LE, West SK, Barron Y, Cid-Ruzafa J. Anthropometric status and cataract: The Salisbury Eye Evaluation project. Am J Clin Nutr 1999; 69: 237-242.
26. Hiller R, Podgor MJ, Sperduto RD, Nowroozi L, Wilson PW, D'Agostino RB et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998; 105: 1244-1250.
27. Morris MS, Jacques PF, Hankinson SE, Chylack Jr LT, Willett WC, Taylor A. Moderate alcoholic beverage intake and early nuclear and cortical lens opacities. Ophthalmic Epidemiol 2004; 11: 53-65.
28. Klein BE, Klein R, Lee KE, Meuer SM. Socioeconomic and lifestyle factors and the 10-year incidence of age-related cataracts. Am J Ophthalmol 2003; 136: 506-512.
29. Harding JJ. Recent studies of risk factors and protective factors for cataract. Curr Opin Ophthalmol 1997; 8: 46-49.
30. Phillips CI, Clayton RM, Cuthbert J, Qian W, Donnelly CA, Prescott RJ. Human cataract risk factors: Significance of abstention from, and high consumption of, ethanol (U-curve) and non-significance of smoking. Ophthalmic Res 1996; 28: 237-247.
31. Ritter LL, Klein BE, Klein R, Mares-Perlman JA. Alcohol use and lens opacities in the Beaver Dam Eye Study. Arch Ophthalmol 1993; 111: 113-117.
32. Munoz B, Tajchman U, Bochow T, West S. Alcohol use and risk of posterior subcapsular opacities. Arch Ophthalmol 1993; 111: 110-112.
33. Harding JJ, van Heyningen R. Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol 1988; 72: 809-814.
34. Department of Health. Statistics on alcohol: England. 2004; 5: 1-62 (ISBN 1 84182 886 6, http://www.doctors.net.uk/login/ Frameset.aspx?20040929094500).
35. Hennis A, Wu SY, Nemesure B, Leske MC. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 2004; 122: 525-530.
36. Klein BE, Klein R, Lee KE, Danforth LG. Drug use and five-year incidence of age-related cataracts: The Beaver Dam Eye Study. Ophthalmology 2001; 108: 1670-1674.
37. Christen WG, Ajani UA, Schaumberg DA, Glynn RJ, Manson JE, Hennekens CH. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I. Arch Ophthalmol 2001; 119: 405-412.
38. Cumming RG, Mitchell P. Medications and cataract. The Blue Mountains Eye Study. Ophthalmology 1998; 105: 1751-1758.
39. McCarty CA, Taylor HR. A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol 2002; 35: 21-31.
40. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Abbey H et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988; 319: 1429-1433.
41. Klein BE, Klein R, Lee KE. Renal function abnormalities and incident cataract after a five-year interval: The Beaver Dam Eye Study. Curr Eye Res 1998; 17: 720-725.
42. Donnelly CA, Seth J, Clayton RM, Phillips CI, Cuthbert J. Some plasma constituents correlate with human cataract location and nuclear colour. Ophthalmic Res 1997; 29: 207-217.
43. McCarty CA, Mukesh BN, Fu CL, Taylor HR. The epidemiology of cataract in Australia. Am J Ophthalmol 1999; 128: 446-465.
44. Leske MC, Chylack Jr LT, Wu SY. The lens opacities case-control study. Risk factors for cataract. Arch Ophthalmol 1991; 109: 244-251.
45. Leske MC, Wu SY, Hyman L, Sperduto R, Underwood B, Chylack LT et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 1995; 113: 1113-1119.
46. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. The Italian-American Cataract Study Group. Am J Epidemiol 1991; 133: 541-553.
47. Mares-Perlman JA, Klein BE, Klein R, Ritter LL. Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology 1994; 101: 315-325.
48. Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: The Blue Mountains Eye Study. Am J Ophthalmol 2001; 132: 19-26.
49. Cumming RG, Mitchell P, Smith W. Diet and cataract: The Blue Mountains Eye Study. Ophthalmology 2000; 107: 450-456.
50. McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR. Vitamin E supplementation and cataract: Randomized controlled trial. Ophthalmology 2004; 111: 75-84.
51. Chylack Jr LT, Brown NP, Bron A, Hurst M, Kopcke W, Thien U et al. The Roche European American Cataract Trial (REACT): A randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002; 9: 49-80.
52. Mares-Perlman JA, Lyle BJ, Klein R, Fisher AI, Brady WE, VandenLangenberg GM et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol 2000; 118: 1556-1563.
53. Jacques PF, Chylack Jr LT, Hankinson SE, Khu PM, Rogers G, Friend J et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001; 119: 1009-1019.
54. Valero MP, Fletcher AE, De Stavola BL, Vioque J, Alepuz VC. Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr 2002; 132: 1299-1306.
55. Gale CR, Hall NF, Phillips DI, Martyn CN. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 2001; 108: 1992-1998.
56. Klein BE, Klein RE, Lee KE. Incident cataract after a five-year interval and lifestyle factors: The Beaver Dam eye study. Ophthalmic Epidemiol 1999; 6: 247-255.
57. Younan C, Mitchell P, Cumming RG, Panchapakesan J, Rochtchina E, Hales AM. Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: The Blue Mountains Eye Study. Am J Epidemiol 2002; 155: 997-1006.
58. Klein BE, Klein R, Ritter LL. Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 1994; 112: 85-91.
59. Klein BE, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: The Beaver Dam Eye Study. Am J Ophthalmol 2000; 130: 322-326.
60. Freeman EE, Munoz B, Schein OD, West SK. Incidence and progression of lens opacities: Effect of hormone replacement therapy and reproductive factors. Epidemiology 2004; 15: 451-457.
61. Weintraub JM, Taylor A, Jacques P, Willett WC, Rosner B, Colditz GA et al. Postmenopausal hormone use and lens opacities. Ophthalmic Epidemiol 2002; 9: 179-190.
62. Goodrich ME, Cumming RG, Mitchell P, Koutts J, Burnett L. Plasma fibrinogen and other cardiovascular disease risk factors and cataract. Ophthalmic Epidemiol 1999; 6: 279-290.
63. Klein BE, Klein R, Lee KE. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: The Beaver Dam Eye Study. Am J Ophthalmol 1997; 123: 338-346.
64. Meyer D, Parkin D, Maritz FJ, Liebenberg PH. Abnormal serum lipoprotein levels as a risk factor for the development of human lenticular opacities. Cardiovasc J S Afr 2003; 14: 60-64.
65. McCarty CA, Nanjan MB, Taylor HR. Attributable risk estimates for cataract to prioritize medical and public health action. Invest Ophthalmol Vis Sci 2000; 41: 3720-3725.
66. Rowe NG, Mitchell PG, Cumming RG, Wans JJ. Diabetes, fasting blood glucose and age-related cataract: The Blue Mountains Eye Study. Ophthalmic Epidemiol 2000; 7: 103-114.
67. McCarty CA, Lee SE, Livingston PM, Bissinella M, Taylor HR. Ocular exposure to UV-B in sunlight: The Melbourne visual impairment project model. Bull World Health Organ 1996; 74: 353-360.
68. Minassian DC, Mehra V, Jones BR. Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet 1984; 1: 751-753.
69. Harding JJ, Harding RS, Egerton M. Risk factors for cataract in Oxfordshire: Diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea. Acta Ophthalmol (Copenh) 1989; 67: 510-517.
70. Bingham SA, Welch AA, McTaggart A, Mulligan AA, Runswick SA, Luben R et al. Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr 2001; 4: 847-858.